Mark J. Lewis
Education
Ph.D., economics, Massachusetts Institute of Technology; M.A., economics, Queen’s University; B.Sc., mathematics and economics, Dalhousie University
Summary of Experience
Dr. Lewis provides economic analysis and expert witness support in a wide range of litigation matters, including antitrust, class certification, and health care cases. His case work has involved cartel allegations in a variety of industries, alleged horizontal and vertical restraints by manufacturers in the technology and construction industries, antitrust claims against brand and generic drug manufacturers, and transfer pricing disputes. Prior to joining Analysis Group, Dr. Lewis was a manager in the economic and statistical consulting group of a financial advisory firm.
- Apple Inc. v. Qualcomm Inc. (antitrust)
- Federal Trade Commission v. Qualcomm Inc.
- High-Tech Employee Class Action Involving Alleged No-Poaching Agreements
- In re: Optical Disk Drive Products Antitrust Litigation
- TravelPass Group LLC et al. v. Caesars Entertainment Corp. et al.
- US v. Penn, et al.
- Wellbutrin XL Antitrust Litigation
-
Economics – Overview (Measurement-Error Bias in Overcharge Calculations)
Global Competition Review: Europe, Middle East and Africa Antitrust Review 2021, July 2020
2020 -
Donning And Doffing Damages: Tyson Takeaways For Antitrust
Law360, May 12, 2016
2016 -
-
-
-
Average overcharge models and determining individual harm in collective actions
Concurrences N° 2-2015, pp. 38-44
2015
-
April 20, 2023
-
August 12, 2022
-
August 12, 2021
-
AG Feature Implications of the Tyson Ruling for Class Certification -
NewsAnalysis Group Experts Publish Article Examining Ascertainability in Class Certification
-
Health Care Bulletin The Myth of “Price Disconnects” in U.S. Pharma Markets
-
NewsManaging Principal Aaron Yeater and Vice President Mark Lewis Publish Law360 Article on Implications of Recent US Supreme Court Decision